Cargando…

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation

BACKGROUND: Sarcomatoid renal cell cancer (RCC) is a distinct histological variant of RCC that is associated with rapid progression and a poor prognosis. The optimal treatment for patients with sarcomatoid RCC remains to be defined. Gemcitabine plus doxorubicine (GD) has shown some efficacy, however...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staehler, M, Haseke, N, Roosen, A, Stadler, T, Bader, M, Siebels, M, Karl, A, Stief, CG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351952/ https://www.ncbi.nlm.nih.gov/pubmed/20696639 http://dx.doi.org/10.1186/2047-783X-15-7-287

Ejemplares similares

Profile of temsirolimus in the treatment of advanced renal cell carcinoma
por: Staehler, Michael, et al.
Publicado: (2010)

Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed
por: Paredes Mogica, Jan Alberto, et al.
Publicado: (2021)

Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma
por: NUMAKURA, KAZUYUKI, et al.
Publicado: (2014)

Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
por: Schlenker, B, et al.
Publicado: (2010)

Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?
por: Shing, Kit, et al.
Publicado: (2020)

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
por: Lee, J K, et al.
Publicado: (2013)

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling
por: Julka, P K, et al.
Publicado: (2008)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

Sarcomatoid Renal Cell Carcinoma Metastasis to the Penis
por: Liou, Victor D., et al.
Publicado: (2015)

Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
por: Lichtbroun, Benjamin J., et al.
Publicado: (2023)

Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia
por: Ahmad, H. R., et al.
Publicado: (2017)

Perioperative blood loss in open retropubic radical prostatectomy - is it safe to get operated at an educational hospital?
por: Karl, A, et al.
Publicado: (2009)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
por: Stemmler, H J, et al.
Publicado: (2011)

Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma
por: Saliby, Renee Maria, et al.
Publicado: (2023)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
por: El Dika, Imane, et al.
Publicado: (2020)

Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma
por: Safavi, Moeinadin, et al.
Publicado: (2016)

Sarcomatoid renal cell carcinoma with rhabdoid features
por: Al-Saidi, Nagla Ahmed, et al.
Publicado: (2013)

Cardiac Involvement in Sarcomatoid Renal Cell Carcinoma
por: Mohamed, Amr, et al.
Publicado: (2021)

Small Renal Mass with Sarcomatoid Features: Erratum
Publicado: (2021)

Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non‐sarcomatoid renal carcinomas
por: Sircar, Kanishka, et al.
Publicado: (2015)

Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue Sarcoma
por: Liu, Zhiyong, et al.
Publicado: (2022)

Short-term effective treatment of CNS metastasis of sarcomatoid renal cell carcinoma with temozolomide and pegylated liposomal doxorubicin: A case report
por: Beier, Dagmar, et al.
Publicado: (2008)

Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-Based Chemotherapy
por: Merimsky, Ofer, et al.
Publicado: (2000)

Sarcomatoid renal cell carcinoma: biology, natural history and management
por: Blum, Kyle A., et al.
Publicado: (2020)

Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020)

Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort
por: Trédan, Olivier, et al.
Publicado: (2023)

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial
por: Choueiri, T.K., et al.
Publicado: (2021)

Sarcomatoid renal cell carcinoma: MRI features and their association with survival
por: Cheng, Monica, et al.
Publicado: (2023)

Sarcomatoid carcinoma of the renal pelvis: A case report
por: TIAN, XIQUAN, et al.
Publicado: (2014)

Sarcomatoid Chromophobe Renal Cell Carcinoma with Heterologous Component
por: Bharti, Sushma, et al.
Publicado: (2020)

Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
por: Anraku, Tsutomu, et al.
Publicado: (2023)

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
por: Bakouny, Ziad, et al.
Publicado: (2021)

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
por: Awasthi, Niranjan, et al.
Publicado: (2013)

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
por: de Jong, Evelien J. M., et al.
Publicado: (2021)

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2022)

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
por: Melisi, Davide, et al.
Publicado: (2018)

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer
por: D'Agostino, G, et al.
Publicado: (2003)

Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma
por: Wang, Zhixian, et al.
Publicado: (2018)

Sarcomatoid carcinoma of the cervix
por: Nageeti, Tahani H., et al.
Publicado: (2012)

Gemcitabine plus S-1 for metastatic pancreatic cancer
por: Zhu, Hong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jjb4k4d578hpp55mph2cgan0pm